This protocol is judged by an institutional evaluate board, an independent group that assessments any clinical trials involving humans. If a review includes a Program I drug, after the board approves the protocol as ethical, the researchers really have to apply for an investigational new drug (IND) variety from your FDA.He mentioned he appreciated